Clinical Trial Update: Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability data for BSI-045B in healthy adults and patients with atopic dermatitis are presented.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• BSI-045B

Snippet

Sponsor: Biosion, Inc. | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED